NCT00399477View on ClinicalTrials.gov

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Parkinson's Disease

Interventions

DRUG

rasagiline mesylate

Azilect®

DRUG

Rasagiline mesylate plus Mirapex

Mirapex, Azilect®

DRUG

Rasagiline mesylate with Levodopa

Azilect®, Levodopa

DRUG

Rasagiline mesylate with Requip

Azilect®, Requip

All Listed Sponsors

lead

Teva Neuroscience, Inc.

INDUSTRY

NCT00399477 - A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease | Biotech Hunter | Biotech Hunter